Africa CDC chief urges African governments to fund their own Ebola response

Africa CDC Director-General Jean Kaseya is pressing African governments to finance more of the Ebola response and vaccine development themselves as the outbreak in Congo and Uganda worsens.

The appeal comes as health workers are still tracing more than 35,000 contacts and trying to contain a cross-border outbreak that has already killed more than 200 people out of 894 confirmed cases, according to AP reporting.

Funding push

Kaseya said Africa needs to invest more of its own money in outbreak response and vaccine work instead of relying so heavily on external support.

He argued that the continent's public-health needs are outpacing its domestic financing and manufacturing base.

Kaseya said Africa produces less than 1% of its vaccines and about 3% of its medicines. In his view, that leaves the region exposed when an outbreak accelerates across borders.

He also pointed to existing but limited financing efforts. An African Epidemic Fund has raised $80 million from governments, and a donor conference brought in $910 million.

Those sums show that money is flowing into public-health preparedness, but they also highlight how much larger the need is for durable local funding.

Outbreak spreading

The warning comes during a fast-moving outbreak centered in eastern Congo that has spread into Uganda.

AP reported on June 19 that Congo's Ituri region accounts for more than 90% of cases. The same report said Uganda had recorded 19 cases and two deaths.

Another AP report on June 19 said mourners in Bunia buried a 6-month-old Ebola victim, underscoring the toll on families and the severity of the outbreak in the region.

The outbreak is being driven by the Bundibugyo strain, which complicates planning because it does not yet have an approved vaccine.

That leaves response teams relying heavily on surveillance, treatment, contact tracing, and containment while vaccine development and procurement remain unfinished.

Response on the ground

Congo's health ministry has announced free treatment in Ituri and increased bonuses for health workers, according to AP reporting from June 19.

Those measures are meant to encourage people to seek care sooner and help retain staff working in difficult conditions.

The outbreak's spread across the Congo-Uganda border has also raised the workload for health workers and contact-tracing teams in both countries.

The strain on local systems is significant because the response has to keep pace with new chains of transmission while still monitoring tens of thousands of contacts.

Why it matters

Kaseya's message is not only about one outbreak. It is about whether African governments can build stronger financing and manufacturing capacity before the next emergency hits.

The current response depends on a combination of national health ministries, Africa CDC, the World Health Organization, and outside funding. Kaseya is arguing that the balance needs to shift.

He has framed vaccine capacity as part of that problem. If Africa continues to produce only a small share of its vaccines and medicines, the continent will remain dependent on outside supply when time matters most.

The outbreak is also a test of whether local funding can support faster response operations, treatment capacity, and vaccine work at the same time.

What comes next

The key questions now are whether Congo, Uganda, or other African governments announce new funding commitments after Kaseya's appeal.

Another near-term watch point is whether Africa CDC, Congo's health ministry, Uganda's health authorities, or the World Health Organization publish updated totals as the outbreak develops.

It will also matter whether vaccine-development or procurement efforts for the Bundibugyo strain move faster after the funding push.

For now, the outbreak remains active, the contact-tracing burden remains large, and the debate over who pays for the response has become part of the public-health emergency itself.